Pitavastatin lactone
A major phase 2 metabolite of pitavastatin

Catalog Number | 21785 |
Research Area | Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Cardiovascular System|Cardiovascular Diseases|Heart Failure||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cardiovascular System|Lipids & Lipoproteins|Cholesterol Metabolism||Research Area|Cardiovascular System|Lipids & Lipoproteins|Lipoproteins||Research Area|Endocrinology & Metabolism|Inborn Errors of Metabolism||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias||Research Area|Toxicology & Xenobiotic Metabolism|Drug Metabolites||Research Area|Toxicology & Xenobiotic Metabolism|UDP Glucuronosyltransferases|UGT1A1||Research Area|Toxicology & Xenobiotic Metabolism|UDP Glucuronosyltransferases|UGT1A3||Research Area|Toxicology & Xenobiotic Metabolism|UDP Glucuronosyltransferases|UGT2B7 |
Molecular Formula | C25H22FNO3 |
CAS# | 141750-63-2 |
Purity | ≥98% |
Inchi | InChI=1S/C25H22FNO3/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-19-13-18(28)14-23(29)30-19/h1-4,7-12,16,18-19,28H,5-6,13-14H2/b12-11+/t18-,19-/m1/s1 |
Inchi Key | XJVKVAFYQRWVAJ-MCBHFWOFSA-N |
SMILES | FC(C=C1)=CC=C1C2=C(/C=C/[C@H]3OC(C[C@H](O)C3)=O)C(C4CC4)=NC5=C2C=CC=C5 |
Size | 5 mg |
Supplier Page | https://www.caymanchem.com/product/21785 |